Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Introduction. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) imposes a huge economic burden on healthcare systems worldwide. Chinese herbal injections (CHIs) are widely used to treat AECOPD. In this study, we examined the efficacy of CHIs in the treatment of AECOPD using a netw...

Full description

Saved in:
Bibliographic Details
Published in:Evidence-based complementary and alternative medicine 2018-01, Vol.2018 (2018), p.1-11
Main Authors: Zhang, Xiaomeng, Zhang, Dan, Zhao, Yi, Wang, Kaihuan, Huang, Xingyue, Wu, Jiarui, Duan, Xiaojiao, Liu, Xinkui
Format: Article
Language:English
Subjects:
Bayesian analysis
Blood
C-reactive protein
Chinese medicine
Chronic obstructive pulmonary disease
Clinical trials
Comparative analysis
Computer software industry
Drug therapy
Evidence-based medicine
Herbal medicine
Injection
Lung diseases
Lung diseases, Obstructive
Medical research
Meta-analysis
Obstructive lung disease
Pharmacy
Randomization
Research methodology
Review
Software
Systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c499t-2ba6a1e6a4d35fa314a162a5b8a10f608c49daedfd53e4d47e018cbe598089173
cites cdi_FETCH-LOGICAL-c499t-2ba6a1e6a4d35fa314a162a5b8a10f608c49daedfd53e4d47e018cbe598089173
container_end_page 11
container_issue 2018
container_start_page 1
container_title Evidence-based complementary and alternative medicine
container_volume 2018
creator Zhang, Xiaomeng
Zhang, Dan
Zhao, Yi
Wang, Kaihuan
Huang, Xingyue
Wu, Jiarui
Duan, Xiaojiao
Liu, Xinkui
description Introduction. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) imposes a huge economic burden on healthcare systems worldwide. Chinese herbal injections (CHIs) are widely used to treat AECOPD. In this study, we examined the efficacy of CHIs in the treatment of AECOPD using a network meta-analysis (NMA). Methods. Literature search was conducted from electronic databases of randomized controlled trials (RCTs) on CHIs plus Western medicine (WM) versus WM. WinBUGS 1.4.3 and STATA 12.0 were adopted to compute calculations and prepare graphs, respectively. Results. We included 155 RCTs with 13,218 patients. The results revealed that Danhong injection (DH) + WM had the greatest therapeutic potential in terms of rate of clinical efficacy (RCE). In addition, in comprehensively improving RCE and FEV1%, and RCE and C-reactive protein, Huangqi injection (HQ) +WM was associated with preferable effects. Similarly, Xixinnao injection + WM, Reduning injection (RDN) +WM, and HQ+WM had a favorable effect on RCE and PaO2. The effect of RDN+WM was favorable in all outcomes except RCE. The safety of CHIs needs to be further assessed. Conclusions. Based on this NMA, DH+WM, HQ+WM, and RDN+WM were potential optimal therapies in AECOPD and their safety should be strictly monitored.
doi_str_mv 10.1155/2018/7942936
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6076913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A604313394</galeid><sourcerecordid>A604313394</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-2ba6a1e6a4d35fa314a162a5b8a10f608c49daedfd53e4d47e018cbe598089173</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEoqVw44wscUGCpXbixA4HpCUUWqlQhBaJmzVxJlsvib3YScvy2_hxOOyyBU6cZiQ_886H3yR5yOhzxvL8OKVMHouSp2VW3EoOmeBsxlMpb-9z8fkguRfCitK0FELcTQ4yymhOi-Iw-VG5fg0eBnOF5KRtjQa9Ia4l1aWxGJCcoq-hI2d2hXowzgbSOk8WHmOJXZK5HodY-A30xE3Attg7azS5qMPgR_1L_MPY9c6C35DXJiAEfEHm5BVsMBiw5D0O185_Ie9wgNncQrcJJkxSH8E2rjffsSGVs4N3XRfThTfQhfvJnTYGfLCLR8mnNyeL6nR2fvH2rJqfzzQvy2GW1lAAwwJ4k-UtZIwDK1LIawmMtgWVEWsAm7bJM-QNFxhPqmvMS0llyUR2lLzc6q7HusdGY5wDOrX2po_7KAdG_f1izaVauitVUFGULIsCT3YC3n0dMQyqN0Fj14FFNwaVUinj__FMRvTxP-jKjT4eZKKE5IJKwW6oJXSojG1d7KsnUTUvKM9iz5JH6tmW0t6F4LHdj8yomsyjJvOonXki_ujPNffwb7dE4OkWiN5o4Nr8pxxGBlu4oVleZDzPfgK8dNk6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2078470871</pqid></control><display><type>article</type><title>Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials</title><source>Publicly Available Content Database</source><source>Wiley Open Access Journals</source><creator>Zhang, Xiaomeng ; Zhang, Dan ; Zhao, Yi ; Wang, Kaihuan ; Huang, Xingyue ; Wu, Jiarui ; Duan, Xiaojiao ; Liu, Xinkui</creator><contributor>Worsnop, Christopher ; Christopher Worsnop</contributor><creatorcontrib>Zhang, Xiaomeng ; Zhang, Dan ; Zhao, Yi ; Wang, Kaihuan ; Huang, Xingyue ; Wu, Jiarui ; Duan, Xiaojiao ; Liu, Xinkui ; Worsnop, Christopher ; Christopher Worsnop</creatorcontrib><description>Introduction. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) imposes a huge economic burden on healthcare systems worldwide. Chinese herbal injections (CHIs) are widely used to treat AECOPD. In this study, we examined the efficacy of CHIs in the treatment of AECOPD using a network meta-analysis (NMA). Methods. Literature search was conducted from electronic databases of randomized controlled trials (RCTs) on CHIs plus Western medicine (WM) versus WM. WinBUGS 1.4.3 and STATA 12.0 were adopted to compute calculations and prepare graphs, respectively. Results. We included 155 RCTs with 13,218 patients. The results revealed that Danhong injection (DH) + WM had the greatest therapeutic potential in terms of rate of clinical efficacy (RCE). In addition, in comprehensively improving RCE and FEV1%, and RCE and C-reactive protein, Huangqi injection (HQ) +WM was associated with preferable effects. Similarly, Xixinnao injection + WM, Reduning injection (RDN) +WM, and HQ+WM had a favorable effect on RCE and PaO2. The effect of RDN+WM was favorable in all outcomes except RCE. The safety of CHIs needs to be further assessed. Conclusions. Based on this NMA, DH+WM, HQ+WM, and RDN+WM were potential optimal therapies in AECOPD and their safety should be strictly monitored.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2018/7942936</identifier><identifier>PMID: 30105066</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Bayesian analysis ; Blood ; C-reactive protein ; Chinese medicine ; Chronic obstructive pulmonary disease ; Clinical trials ; Comparative analysis ; Computer software industry ; Drug therapy ; Evidence-based medicine ; Herbal medicine ; Injection ; Lung diseases ; Lung diseases, Obstructive ; Medical research ; Meta-analysis ; Obstructive lung disease ; Pharmacy ; Randomization ; Research methodology ; Review ; Software ; Systematic review</subject><ispartof>Evidence-based complementary and alternative medicine, 2018-01, Vol.2018 (2018), p.1-11</ispartof><rights>Copyright © 2018 Xiaojiao Duan et al.</rights><rights>COPYRIGHT 2018 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2018 Xiaojiao Duan et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2018 Xiaojiao Duan et al. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-2ba6a1e6a4d35fa314a162a5b8a10f608c49daedfd53e4d47e018cbe598089173</citedby><cites>FETCH-LOGICAL-c499t-2ba6a1e6a4d35fa314a162a5b8a10f608c49daedfd53e4d47e018cbe598089173</cites><orcidid>0000-0002-1617-6110</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2078470871/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2078470871?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,25732,27903,27904,36991,36992,44569,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30105066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Worsnop, Christopher</contributor><contributor>Christopher Worsnop</contributor><creatorcontrib>Zhang, Xiaomeng</creatorcontrib><creatorcontrib>Zhang, Dan</creatorcontrib><creatorcontrib>Zhao, Yi</creatorcontrib><creatorcontrib>Wang, Kaihuan</creatorcontrib><creatorcontrib>Huang, Xingyue</creatorcontrib><creatorcontrib>Wu, Jiarui</creatorcontrib><creatorcontrib>Duan, Xiaojiao</creatorcontrib><creatorcontrib>Liu, Xinkui</creatorcontrib><title>Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Introduction. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) imposes a huge economic burden on healthcare systems worldwide. Chinese herbal injections (CHIs) are widely used to treat AECOPD. In this study, we examined the efficacy of CHIs in the treatment of AECOPD using a network meta-analysis (NMA). Methods. Literature search was conducted from electronic databases of randomized controlled trials (RCTs) on CHIs plus Western medicine (WM) versus WM. WinBUGS 1.4.3 and STATA 12.0 were adopted to compute calculations and prepare graphs, respectively. Results. We included 155 RCTs with 13,218 patients. The results revealed that Danhong injection (DH) + WM had the greatest therapeutic potential in terms of rate of clinical efficacy (RCE). In addition, in comprehensively improving RCE and FEV1%, and RCE and C-reactive protein, Huangqi injection (HQ) +WM was associated with preferable effects. Similarly, Xixinnao injection + WM, Reduning injection (RDN) +WM, and HQ+WM had a favorable effect on RCE and PaO2. The effect of RDN+WM was favorable in all outcomes except RCE. The safety of CHIs needs to be further assessed. Conclusions. Based on this NMA, DH+WM, HQ+WM, and RDN+WM were potential optimal therapies in AECOPD and their safety should be strictly monitored.</description><subject>Bayesian analysis</subject><subject>Blood</subject><subject>C-reactive protein</subject><subject>Chinese medicine</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Clinical trials</subject><subject>Comparative analysis</subject><subject>Computer software industry</subject><subject>Drug therapy</subject><subject>Evidence-based medicine</subject><subject>Herbal medicine</subject><subject>Injection</subject><subject>Lung diseases</subject><subject>Lung diseases, Obstructive</subject><subject>Medical research</subject><subject>Meta-analysis</subject><subject>Obstructive lung disease</subject><subject>Pharmacy</subject><subject>Randomization</subject><subject>Research methodology</subject><subject>Review</subject><subject>Software</subject><subject>Systematic review</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkk1v1DAQhiMEoqVw44wscUGCpXbixA4HpCUUWqlQhBaJmzVxJlsvib3YScvy2_hxOOyyBU6cZiQ_886H3yR5yOhzxvL8OKVMHouSp2VW3EoOmeBsxlMpb-9z8fkguRfCitK0FELcTQ4yymhOi-Iw-VG5fg0eBnOF5KRtjQa9Ia4l1aWxGJCcoq-hI2d2hXowzgbSOk8WHmOJXZK5HodY-A30xE3Attg7azS5qMPgR_1L_MPY9c6C35DXJiAEfEHm5BVsMBiw5D0O185_Ie9wgNncQrcJJkxSH8E2rjffsSGVs4N3XRfThTfQhfvJnTYGfLCLR8mnNyeL6nR2fvH2rJqfzzQvy2GW1lAAwwJ4k-UtZIwDK1LIawmMtgWVEWsAm7bJM-QNFxhPqmvMS0llyUR2lLzc6q7HusdGY5wDOrX2po_7KAdG_f1izaVauitVUFGULIsCT3YC3n0dMQyqN0Fj14FFNwaVUinj__FMRvTxP-jKjT4eZKKE5IJKwW6oJXSojG1d7KsnUTUvKM9iz5JH6tmW0t6F4LHdj8yomsyjJvOonXki_ujPNffwb7dE4OkWiN5o4Nr8pxxGBlu4oVleZDzPfgK8dNk6</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Zhang, Xiaomeng</creator><creator>Zhang, Dan</creator><creator>Zhao, Yi</creator><creator>Wang, Kaihuan</creator><creator>Huang, Xingyue</creator><creator>Wu, Jiarui</creator><creator>Duan, Xiaojiao</creator><creator>Liu, Xinkui</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1617-6110</orcidid></search><sort><creationdate>20180101</creationdate><title>Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials</title><author>Zhang, Xiaomeng ; Zhang, Dan ; Zhao, Yi ; Wang, Kaihuan ; Huang, Xingyue ; Wu, Jiarui ; Duan, Xiaojiao ; Liu, Xinkui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-2ba6a1e6a4d35fa314a162a5b8a10f608c49daedfd53e4d47e018cbe598089173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Bayesian analysis</topic><topic>Blood</topic><topic>C-reactive protein</topic><topic>Chinese medicine</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Clinical trials</topic><topic>Comparative analysis</topic><topic>Computer software industry</topic><topic>Drug therapy</topic><topic>Evidence-based medicine</topic><topic>Herbal medicine</topic><topic>Injection</topic><topic>Lung diseases</topic><topic>Lung diseases, Obstructive</topic><topic>Medical research</topic><topic>Meta-analysis</topic><topic>Obstructive lung disease</topic><topic>Pharmacy</topic><topic>Randomization</topic><topic>Research methodology</topic><topic>Review</topic><topic>Software</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Xiaomeng</creatorcontrib><creatorcontrib>Zhang, Dan</creatorcontrib><creatorcontrib>Zhao, Yi</creatorcontrib><creatorcontrib>Wang, Kaihuan</creatorcontrib><creatorcontrib>Huang, Xingyue</creatorcontrib><creatorcontrib>Wu, Jiarui</creatorcontrib><creatorcontrib>Duan, Xiaojiao</creatorcontrib><creatorcontrib>Liu, Xinkui</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Xiaomeng</au><au>Zhang, Dan</au><au>Zhao, Yi</au><au>Wang, Kaihuan</au><au>Huang, Xingyue</au><au>Wu, Jiarui</au><au>Duan, Xiaojiao</au><au>Liu, Xinkui</au><au>Worsnop, Christopher</au><au>Christopher Worsnop</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>2018</volume><issue>2018</issue><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Introduction. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) imposes a huge economic burden on healthcare systems worldwide. Chinese herbal injections (CHIs) are widely used to treat AECOPD. In this study, we examined the efficacy of CHIs in the treatment of AECOPD using a network meta-analysis (NMA). Methods. Literature search was conducted from electronic databases of randomized controlled trials (RCTs) on CHIs plus Western medicine (WM) versus WM. WinBUGS 1.4.3 and STATA 12.0 were adopted to compute calculations and prepare graphs, respectively. Results. We included 155 RCTs with 13,218 patients. The results revealed that Danhong injection (DH) + WM had the greatest therapeutic potential in terms of rate of clinical efficacy (RCE). In addition, in comprehensively improving RCE and FEV1%, and RCE and C-reactive protein, Huangqi injection (HQ) +WM was associated with preferable effects. Similarly, Xixinnao injection + WM, Reduning injection (RDN) +WM, and HQ+WM had a favorable effect on RCE and PaO2. The effect of RDN+WM was favorable in all outcomes except RCE. The safety of CHIs needs to be further assessed. Conclusions. Based on this NMA, DH+WM, HQ+WM, and RDN+WM were potential optimal therapies in AECOPD and their safety should be strictly monitored.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>30105066</pmid><doi>10.1155/2018/7942936</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1617-6110</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-427X
ispartof Evidence-based complementary and alternative medicine, 2018-01, Vol.2018 (2018), p.1-11
issn 1741-427X
1741-4288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6076913
source Publicly Available Content Database; Wiley Open Access Journals
subjects Bayesian analysis
Blood
C-reactive protein
Chinese medicine
Chronic obstructive pulmonary disease
Clinical trials
Comparative analysis
Computer software industry
Drug therapy
Evidence-based medicine
Herbal medicine
Injection
Lung diseases
Lung diseases, Obstructive
Medical research
Meta-analysis
Obstructive lung disease
Pharmacy
Randomization
Research methodology
Review
Software
Systematic review
title Comparative Efficacy of Chinese Herbal Injections for Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T21%3A49%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20Efficacy%20of%20Chinese%20Herbal%20Injections%20for%20Treating%20Acute%20Exacerbation%20of%20Chronic%20Obstructive%20Pulmonary%20Disease:%20A%20Bayesian%20Network%20Meta-Analysis%20of%20Randomized%20Controlled%20Trials&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Zhang,%20Xiaomeng&rft.date=2018-01-01&rft.volume=2018&rft.issue=2018&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2018/7942936&rft_dat=%3Cgale_pubme%3EA604313394%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-2ba6a1e6a4d35fa314a162a5b8a10f608c49daedfd53e4d47e018cbe598089173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2078470871&rft_id=info:pmid/30105066&rft_galeid=A604313394&rfr_iscdi=true